Quick Answer
NOVAVAX INC reported Stockholders Equity of -$127.75 million for fiscal year 2025.
NOVAVAX INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$127.75M | +79.5% |
| 2024 | -$623.84M | +13.0% |
| 2023 | -$716.93M | -13.1% |
| 2022 | -$634.08M | -80.3% |
| 2021 | -$351.67M | -156.1% |
| 2020 | $627.21M | +437.2% |
| 2019 | -$186.02M | -10.8% |
| 2018 | -$167.94M | -65.1% |
| 2017 | -$101.73M | -1734.3% |
| 2016 | -$5.55M | -101.9% |
| 2015 | $292.67M | +27.5% |
| 2014 | $229.62M | +13.0% |
| 2013 | $203.23M | +153.3% |
| 2012 | $80.24M | +49.0% |
| 2011 | $53.85M | -8.8% |
| 2010 | $59.05M | -15.6% |
| 2009 | $69.95M | +62.9% |
| 2008 | $42.95M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$156.67M | +70.2% | -516.4% |
| June 30, 2025 | $37.62M | +108.7% | +149.7% |
| March 31, 2025 | -$75.64M | +91.3% | +87.9% |
| December 31, 2024 | -$623.84M | +13.0% | -18.5% |
| September 30, 2024 | -$526.44M | +22.4% | -21.9% |
| June 30, 2024 | -$431.71M | +42.8% | +50.2% |
| March 31, 2024 | -$867.08M | +3.2% | -20.9% |
| December 31, 2023 | -$716.93M | -13.1% | -5.7% |
- NOVAVAX INC showed an increase of +79.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, NOVAVAX INC’s stockholders equity has declined by 397.5% (from $42.95 million to -$127.75 million).
- The most recent figure is from NOVAVAX INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: